| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | EVP, Chief Financial Officer | Director
3 companies
Lucera Erick is an EVP, Chief Financial Officer at Editas Medicine, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 2 sells.
Estimated insider holdings value: $1.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | EDIT Editas Medicine, Inc. | EVP, Chief Financial Officer | Sell | 4,109 | $1.71 | $7,029.68 | -3.5% | +0.6% | +25.0% | |
| Aug 14, 2024 | XAIR Beyond Air, Inc. | Director | Buy | 39,266 | $0.40 | $15,565.04 | +904.3% | +23.5% | -71.0% | |
| May 20, 2024 | EDIT Editas Medicine, Inc. | EVP, Chief Financial Officer | Sell | 22,337 | $5.61 | $125,404.39 | -16.1% | -25.7% | -70.3% | |
| Mar 16, 2023 | XAIR Beyond Air, Inc. | Director | Buy | 2,000 | $6.82 | $13,634.00 | +85.4% | -15.5% | -77.3% |